ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "The Altissimo Study using a TKI for nAMD"
Episode Synopsis
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
More episodes of the podcast Retina Synthesis
Stem Cell Therapy for Geographic Atrophy
19/11/2025
8 mg Aflibercept in Diabetic Macular Edema
08/10/2025
Subretinal Gene Therapy for Neovascular AMD
03/10/2025
In God we trust